GENVEC INC Uncategorized Contracts & Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AMENDMENT NO. 1 TO RIGHTS AGREEMENT
GENVEC INC
DE
2017
SECURITIESPURCHASE AGREEMENT
GENVEC INC
NY
2016
SCHEDULE I SCHEDULE OF INVESTORS
GENVEC INC
NY
2014
11.THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
GENVEC INC
2013
AMENDMENT NO. 1 TO SALARY CONTINUATIONAGREEMENT
GENVEC INC
2013
EmploymentAgreement
GENVEC INC
MD
2012
BASICORDERING AGREEMENT # 10XS020 INTRODUCTION
GENVEC INC
2010
LICENSEAGREEMENT
GENVEC INC
IL
2010
LICENSEAGREEMENT
GENVEC INC
IL
2010
SCHEDULEI SCHEDULEOF INVESTORS
GENVEC INC
NY
2010
Name of Investor: By: Name: Title: AGREED AND ACCEPTED: GENVEC, INC. By: Name: Title: 2
GENVEC INC
NY
2008
GENVEC, INC.
GENVEC INC
NY
2008
GENVEC, INC.
GENVEC INC
NY
2008
OTHER TRANSACTION (OT) AGREEMENT OTHER TRANSACTION FOR PROTOTYPE AGREEMENT
GENVEC INC
2007
Very truly yours, RODMAN & RENSHAW, LLC By: Name: Title: Address for notice: 1270 Avenue of the Americas, 16th Floor New York, NY, 10020
GENVEC INC
NY
2006
- 1- -
GENVEC INC
MD
2005
- 1- -
GENVEC INC
2005
TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer
GENVEC INC
NY
2004
TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer
GENVEC INC
DE
2004
TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer
GENVEC INC
2004
TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer
GENVEC INC
DE
2004
AMENDMENT NO. 1 TO RIGHTS AGREEMENT
GENVEC INC
2003